NCT00902993View on ClinicalTrials.gov

Study to Investigate Safety, Tolerability and Pharmacokinetics With Single and Multiple Ascending Doses of AZD1446

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2009

Study Completion Date

September 30, 2009

Conditions
Healthy
Interventions
DRUG

AZD1446

Solution, oral single and multiple dose

DRUG

Placebo

Placebo

Trial Locations (2)

Unknown

Research Site, Gothenburg

Research Site, Stockholm

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY